Clinical audit: virological and immunological response to combination antiretroviral therapy in HIV patients at a Sydney sexual health clinic

被引:1
|
作者
Hsu, D. C. [1 ]
Quin, J. W. [2 ,3 ]
机构
[1] Royal Prince Alfred Hosp, Dept Immunol, Sydney SW Area Hlth Serv, Camperdown, NSW 2050, Australia
[2] Liverpool Hlth Serv, Div Med, Sydney, NSW, Australia
[3] Univ New S Wales, Sydney, NSW, Australia
关键词
response to antiretroviral therapy; clinical audit; HIV virological control; HIV immunological response; PROTEASE INHIBITOR THERAPY; CELL COUNT; HIV-1-INFECTED PATIENTS; INFECTED PATIENTS; RANDOMIZED-TRIAL; PREDICTORS; FAILURE; INITIATION; INCREASES; ADHERENCE;
D O I
10.1111/j.1445-5994.2009.01983.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: Bigge Park Centre (BPC) is a sexual health clinic located in a socially disadvantaged area in Southwest Sydney. This served as a retrospective clinical audit, documenting patient demographics, identifying factors associated with virological, immunological and discordant responses, evaluating the centre's ability in HIV control and investigating changes in practice from 1996 to 2007. Method: Data including age, gender, ethnicity, mode of transmission, hepatitis co-infection, prior acquired immune deficiency syndrome (AIDS)-defining-illness, HIV-1 RNA and CD4+cell counts of patients on combination antiretroviral therapy (CART) for treatment of HIV with at least 1-year follow up at the BPC were analysed. Results were compared with other cohorts in medical literature. Results: BPC manages HIV patients from diverse backgrounds. Sequential monotherapy was associated with poor virological control, lower CD4+cell recovery and discordant response. When patients who had sequential monotherapy were excluded, Caucasian race, high viral load at 1 month and triple-NRTI (nucleoside reverse transcriptase inhibitor) regimen were associated with lack of virological control. Lower baseline viral load and triple-NRTI regimen were associated with lower CD4+cell recovery. Lower baseline CD4+cell count and prior diagnosis of AIDS were associated with discordant response. Virological control and CD4+cell recovery achieved were comparable to that documented in medical literature. There was no significant change over time in terms of timing of CART initiation, attainment of immunological response or virological control since the late 1990s. Conclusion: HIV control achieved at the BPC was comparable to that reported in medical literature. Enhancement of strategies to promote screening and improve adherence as well as performance of HIV resistance assessment and avoidance of triple-NRTI therapy will likely improve patient care.
引用
收藏
页码:265 / 274
页数:10
相关论文
共 50 条
  • [21] Predicting virological decay in patients starting combination antiretroviral therapy
    Hughes, Rachael A.
    Sterne, Jonathan A. C.
    Walsh, John
    Post, Frank
    Nelson, Mark
    Jose, Sophie
    Hill, Teresa
    Tilling, Kate
    Fisherg, Martin
    Dunn, David
    Trevelion, Roy
    Palfreeman, Adrian
    Martin, Fabiola
    Gompels, Mark
    Leen, Clifford
    Johnson, Margaret
    Gilson, Richard
    Anderson, Jane
    Ainsworth, Jonathan
    Hay, Phillip
    Orkin, Chloe
    Kegg, Stephen
    Sabin, Caroline A.
    AIDS, 2016, 30 (11) : 1817 - 1827
  • [22] Distinct patterns of the virological and immunological response to antiretroviral therapy interpreted in terms of the dynamics of immune activation and HIV transmission
    Grossman, Z
    Grossman, Z
    Hunt, PW
    Deeks, SG
    ANTIVIRAL THERAPY, 2003, 8 (03) : U63 - U64
  • [23] Virological response to protease inhibitor therapy in an HIV clinic cohort
    Staszewski, S
    Miller, V
    Sabin, C
    Carlebach, A
    Berger, AM
    Weidmann, E
    Helm, EB
    Hill, A
    Phillips, A
    AIDS, 1999, 13 (03) : 367 - 373
  • [24] Clinical, immunological, and virological outcomes in HIV patients on raltegravir-based salvage therapy
    Deshwal, Rajesh
    Arora, Sumit
    INDIAN JOURNAL OF SEXUALLY TRANSMITTED DISEASES AND AIDS, 2019, 40 (01) : 42 - 45
  • [25] Immunological and epidemiological factors affecting candidiasis in HIV patients beginning antiretroviral therapy in an Asian clinic
    Wulandari, Endah A. T.
    Saraswati, Henny
    Adawiyah, Robiatul
    Djauzi, Samsuridjal
    Wahyuningsih, Retno
    Price, Patricia
    ARCHIVES OF ORAL BIOLOGY, 2017, 82 : 86 - 91
  • [26] CLINICAL, VIROLOGICAL, AND IMMUNOLOGICAL EFFECTS OF COMBINATION THERAPY WITH RIBAVIRIN AND ISOPRINOSINE IN HIV-INFECTED HOMOSEXUAL MEN
    SCHULOF, RS
    PARENTI, DM
    SIMON, GL
    PAXTON, H
    MEYER, WA
    SCHLESSELMAN, SB
    COURTLESS, J
    LELACHEUR, S
    SZTEIN, MB
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1990, 3 (05): : 485 - 492
  • [27] Virological and immunological effects of short-course antiretroviral therapy in primary HIV infection
    Fidler, S
    Oxenius, A
    Brady, M
    Clarke, J
    Cropley, I
    Babiker, A
    Zhang, HT
    Price, D
    Phillips, R
    Weber, J
    AIDS, 2002, 16 (15) : 2049 - 2054
  • [28] Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies
    Braithwaite, R. Scott
    Kozal, Michael J.
    Chang, Chung Chou H.
    Roberts, Mark S.
    Fultz, Shawn L.
    Goetz, Matthew Bidwell
    Gibert, Cynthia
    Rodriguez-Barradas, Maria
    Mole, Larry
    Justice, Amy C.
    AIDS, 2007, 21 (12) : 1579 - 1589
  • [29] Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment
    Lapadula, Giuseppe
    Cozzi-Lepri, Alessandro
    Marchetti, Giulia
    Antinori, Andrea
    Chiodera, Alessandro
    Nicastri, Emanuele
    Parruti, Giustino
    Galli, Massimo
    Gori, Andrea
    Monforte, Antonella d'Arminio
    AIDS, 2013, 27 (05) : 769 - 779
  • [30] Addition of nevirapine to antiretroviral combination regimens in HIV-1+ patients with suppressed plasma viremia:: Immunological and virological effects
    Löw, P
    Dechant, C
    Hauber, I
    Grunke, M
    Rascu, A
    Schmitt, M
    Blank, N
    Kalden, JR
    Harrer, T
    AIDS, 1998, 12 : S51 - S51